{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:30:50Z","timestamp":1788903050037,"version":"build-2803163510"},"reference-count":241,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegeneration involving motor neurons. The 3\u20135 years that patients have to live is marked by day-to-day loss of motor and sometimes cognitive abilities. Enormous amounts of healthcare services and resources are necessary to support patients and their caregivers during this relatively short but burdensome journey. Organization and management of these resources need to best meet patients' expectations and health system efficiency mandates. This can only occur in the setting of multidisciplinary ALS clinics which are known as the gold standard of ALS care worldwide. To introduce this standard to the care of Iranian ALS patients, which is an inevitable quality milestone, a national ALS clinical practice guideline is the necessary first step. The National ALS guideline will serve as the knowledge base for the development of local clinical pathways to guide patient journeys in multidisciplinary ALS clinics. To this end, we gathered a team of national neuromuscular experts as well as experts in related specialties necessary for delivering multidisciplinary care to ALS patients to develop the Iranian ALS clinical practice guideline. Clinical questions were prepared in the Patient, Intervention, Comparison, and Outcome (PICO) format to serve as a guide for the literature search. Considering the lack of adequate national\/local studies at this time, a consensus-based approach was taken to evaluate the quality of the retrieved evidence and summarize recommendations.<\/jats:p>","DOI":"10.3389\/fneur.2023.1154579","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:28:49Z","timestamp":1685701729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Iranian clinical practice guideline for amyotrophic lateral sclerosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Reza","family":"Boostani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Olfati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Shamshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanireh","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Fatehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Arya","family":"Hedjazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Fakharian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Asghar","family":"Okhovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keivan","family":"Basiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Haghi Ashtiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholam Reza","family":"Raissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ahmadreza","family":"Khatoonabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bentolhoda","family":"Ziaadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Yazdchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Bakhtiyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Nafissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr Opin Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00415-019-09652-y","article-title":"Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"267","author":"Xu","year":"2020","journal-title":"J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.1038\/ncomms12408","article-title":"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040","volume":"7","author":"Arthur","year":"2016","journal-title":"Nat Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1468-1331.2010.02972.x","article-title":"Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran","volume":"17","author":"Sajjadi","year":"2010","journal-title":"Eur J Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10654-015-0090-x","article-title":"Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin","volume":"31","author":"Marin","year":"2016","journal-title":"Eur J Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/21678421.2016.1140209","article-title":"Demographic and clinical features of ALS in northeastern Iran from march 2007 through march 2013; a case series study","volume":"17","author":"Boostani","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/21678421.2015.1074698","article-title":"Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study","volume":"16","author":"Shamshiri","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases\/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the el Escorial \u201cclinical limits of amyotrophic lateral sclerosis\u201d workshop contributors","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"World federation of neurology research group on motor neuron D el escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis amyotroph lateral scler other","volume":"1","author":"Brooks","year":"2000","journal-title":"Motor Neuron Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"de Carvalho","year":"2008","journal-title":"Clin Neurophysiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10072-021-05333-9","article-title":"Awaji criteria for the diagnosis of amyotrophic lateral sclerosis in Hanoi, Vietnam","volume":"43","author":"Van Nguyen","year":"2022","journal-title":"Neurol Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8841281","DOI":"10.1155\/2021\/8841281","article-title":"Sensitivity of awaji criteria and revised el escorial criteria in the diagnosis of amyotrophic lateral sclerosis (ALS) at First visit in a tunisian cohort","volume":"2021","author":"Ido","year":"2021","journal-title":"Neurol Res Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0171522","DOI":"10.1371\/journal.pone.0171522","article-title":"The awaji criteria increases the diagnostic sensitivity of the revised el escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population","volume":"12","author":"Li","year":"2017","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1016\/j.clinph.2016.04.005","article-title":"Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data","volume":"127","author":"Geevasinga","year":"2016","journal-title":"Clin Neurophysiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.clinph.2018.11.021","article-title":"Diagnostic criteria for amyotrophic lateral sclerosis: a multicentre study of inter-rater variation and sensitivity","volume":"130","author":"Johnsen","year":"2019","journal-title":"Clin Neurophysiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/mus.27392","article-title":"Gold coast diagnostic criteria: implications for ALS diagnosis and clinical trial enrollment","volume":"64","author":"Vucic","year":"2021","journal-title":"Muscle Nerve."},{"key":"B18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ana.26045","article-title":"Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis","volume":"89","author":"Hannaford","year":"2021","journal-title":"Ann Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-021-00253-2","article-title":"The gold coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a chinese population","volume":"10","author":"Shen","year":"2021","journal-title":"Transl Neurodegener."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1016\/j.clinph.2021.08.014","article-title":"Gold coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis","volume":"132","author":"Pugdahl","year":"2021","journal-title":"Clin Neurophysiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/archneur.1996.00550020045014","article-title":"Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (acts) phase i-ii study group","volume":"53","year":"1996","journal-title":"Arch Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase Iii)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/17482960600888156","article-title":"Excellent inter-rater, intra-rater, and telephone-administered reliability of the Alsfrs-R in a multicenter clinical trial","volume":"8","author":"Kaufmann","year":"2007","journal-title":"Amyotroph Lateral Scler."},{"key":"B24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/jnnp-2016-314661","article-title":"What does the Alsfrs-R really measure?","volume":"88","author":"Rooney","year":"2017"},{"key":"B25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of Alsfrs-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2008.07.016","article-title":"Alsfrs-R score and its ratio: a useful predictor for ALS-progression","volume":"275","author":"Kollewe","year":"2008","journal-title":"J Neurol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/jnnp-2012-304701","article-title":"Evidence of multidimensionality in the Alsfrs-R scale: a critical appraisal on its measurement properties using rasch analysis","volume":"84","author":"Franchignoni","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jphys.2018.07.005","article-title":"Clinimetrics: amyotrophic lateral sclerosis functional rating scale-revised (Alsfrs-R)","volume":"64","author":"Lee","year":"2018","journal-title":"J Physiother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.23736\/S1973-9087.20.06328-5","article-title":"A Further rasch analysis of the fear-avoidance beliefs questionnaire in adults with chronic low back pain suggests the revision of its rating scale","volume":"57","author":"Franchignoni","year":"2021","journal-title":"Eur J Phys Rehabil Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/21678421.2015.1095930","article-title":"Item response theory analysis of the amyotrophic lateral sclerosis functional rating scale-revised in the pooled resource open-access ALS clinical trials database","volume":"17","author":"Bacci","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/awr351","article-title":"A proposed staging system for amyotrophic lateral sclerosis","volume":"135","author":"Roche","year":"2012","journal-title":"Brain."},{"key":"B32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp-2013-306589","article-title":"Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis","volume":"86","author":"Chi\u00f2","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/21678421.2014.897357","article-title":"Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale","volume":"15","author":"Balendra","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B34","doi-asserted-by":"publisher","first-page":"III16-21","DOI":"10.1007\/BF03161085","article-title":"Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis\/motor neurone disease: the ALSAQ-40","volume":"246","author":"Jenkinson","year":"1999","journal-title":"J Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/146608299300080022","article-title":"Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40","volume":"1","author":"Jenkinson","year":"1999","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"B36","first-page":"102","article-title":"Validation of the persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire","volume":"12","author":"Shamshiri","year":"2013","journal-title":"Iran J Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-Ftsd): revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/WNL.0b013e318214359f","article-title":"Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia","volume":"76","author":"Elamin","year":"2011","journal-title":"Neurology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3109\/17482961003727954","article-title":"Detecting frontotemporal dysfunction in ALS: utility of the ALS cognitive behavioral screen (Als-Cbs)","volume":"11","author":"Woolley","year":"2010","journal-title":"Amyotroph Lateral Scler."},{"key":"B40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/21678421.2013.805784","article-title":"Screening for cognition and behaviour changes in ALS","volume":"15","author":"Abrahams","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/21678421.2015.1030430","article-title":"Validation of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (Ecas): a cognitive tool for motor disorders","volume":"16","author":"Niven","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2018.1530264","article-title":"Screening for cognitive and behavioral change in amyotrophic lateral sclerosis\/motor neuron disease: a systematic review of validated screening methods","volume":"20","author":"Simon","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/21678421.2021.1883665","article-title":"Persian adaptation of Edinburgh cognitive and behavioural screen (ECAS)","volume":"22","author":"Mojtabavi","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B44","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/00004691-199511000-00003","article-title":"Motor-unit estimation: the beginning","volume":"12","author":"McComas","year":"1995","journal-title":"J Clin Neurophysiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/mus.20120","article-title":"The use of statistical mune in a multicenter clinical trial","volume":"30","author":"Shefner","year":"2004","journal-title":"Muscle Nerve."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/00207450600936304","article-title":"Motor unit number estimation (Mune) as a quantitative measure of disease progression and motor unit reorganization in amyotrophic lateral sclerosis","volume":"117","author":"Sartucci","year":"2007","journal-title":"Int J Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.clinph.2016.11.026","article-title":"Motor unit number index (Munix) detects motor neuron loss in pre-symptomatic muscles in amyotrophic lateral sclerosis","volume":"128","author":"Neuwirth","year":"2017","journal-title":"Clin Neurophysiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/mus.26087","article-title":"Motor unit number index and neurophysiological index as candidate biomarkers of presymptomatic motor neuron loss in amyotrophic lateral sclerosis","volume":"58","author":"Escorcio-Bezerra","year":"2018","journal-title":"Muscle Nerve."},{"key":"B49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/14737175.2018.1463160","article-title":"Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses","volume":"18","author":"Agosta","year":"2018","journal-title":"Expert Rev Neurother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000509684","article-title":"A Case of cervical spondylotic amyotrophy mimicking amyotrophic lateral sclerosis","volume":"12","author":"Idiculla","year":"2020","journal-title":"Case Rep Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10072-021-05465-y","article-title":"Higher incidence of cervical spinal cord compression in amyotrophic lateral sclerosis: a single-institute cohort study","volume":"43","author":"Matsuzono","year":"2022","journal-title":"Neurol Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1148\/radiol.2019182538","article-title":"Amyotrophic lateral sclerosis versus multifocal motor neuropathy: utility of mr neurography","volume":"292","author":"Kronlage","year":"2019","journal-title":"Radiology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JND-170281","article-title":"The utility of the laboratory work up at the time of diagnosis of amyotrophic lateral sclerosis","volume":"5","author":"Mirian","year":"2018","journal-title":"J Neuromuscul Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13256-019-2256-8","article-title":"Subacute combined degeneration of the spinal cord masking motor neuron disease: a case report","volume":"13","author":"Loveland","year":"2019","journal-title":"J Med Case Rep."},{"key":"B55","unstructured":"McCarterRN WeiderK ChandlerL B12 Deficiency Presenting as an ALS Mimic [Abstract]: PM R.2020"},{"key":"B56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jnnp.60.2.147","article-title":"Avoiding False positive diagnoses of motor neuron disease: lessons from the scottish motor neuron disease register","volume":"60","author":"Davenport","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/archneur.57.1.109","article-title":"Amyotrophic lateral sclerosis mimic syndromes: a population-based study","volume":"57","author":"Traynor","year":"2000","journal-title":"Arch Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.50.6.1795","article-title":"Primary Hyperparathyroidism and ALS: is there a relation?","volume":"50","author":"Jackson","year":"1998","journal-title":"Neurology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0248-8663(01)00498-2","article-title":"Primary hyperparathyroidism, a differential diagnosis of motor neuron diseases","volume":"22","author":"Delmont","year":"2001","journal-title":"Rev Med Interne."},{"key":"B60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1590\/S0004-282X2005000100029","article-title":"Primary hyperparathyroidism simulating motor neuron disease: case report","volume":"63","author":"Carvalho","year":"2005","journal-title":"Arq Neuropsiquiatr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"140085","DOI":"10.1530\/EDM-14-0085","article-title":"Commonly overlooked motor neuron disease mimicker","volume":"2014","author":"Ghosh","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/mus.25376","article-title":"Hypoparathyroidism: a Rare Mimic of Amyotrophic Lateral Sclerosis","volume":"55","author":"Hakeem","year":"2017","journal-title":"Muscle Nerve."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s00415-018-8881-0","article-title":"Motor neuron disease of paraneoplastic origin: a rare but treatable condition","volume":"265","author":"Mele","year":"2018","journal-title":"J Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"577635","DOI":"10.1016\/j.jneuroim.2021.577635","article-title":"A paraneoplastic syndrome misdiagnosed as ALS: what are the red flags? A case report and review of the literature","volume":"358","author":"Tolkovsky","year":"2021","journal-title":"J Neuroimmunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s13760-020-01337-y","article-title":"Amyotrophic lateral sclerosis with coexisting cancer: a single-center study","volume":"121","author":"Akan","year":"2021","journal-title":"Acta Neurol Belg."},{"key":"B68","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/ane.12377","article-title":"Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis","volume":"132","author":"Wolf","year":"2015","journal-title":"Acta Neurol Scand."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00131402-200012000-00003","article-title":"Motor neuron disease and serum monoclonal proteins: poor response to treatment of the paraproteinemia","volume":"2","author":"Juel","year":"2000","journal-title":"J Clin Neuromus Dis."},{"key":"B70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1212\/WNL.84.14_supplement.P4.128","article-title":"Utility of screening for monoclonal gammopathy in ALS (P4.128)","volume":"84","author":"Quesnell","year":"2015","journal-title":"Neurology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/jnnp-2019-321977","article-title":"Igm-gammopathy strongly favours immune treatable MMN and madsam over ALS","volume":"91","author":"Shelly","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.2169\/internalmedicine.54.4645","article-title":"Anti-musk antibody-positive myasthenia gravis mimicking amyotrophic lateral sclerosis","volume":"54","author":"Furuta","year":"2015","journal-title":"Intern Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.nmd.2016.04.004","article-title":"Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis","volume":"26","author":"Huijbers","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/osi2.1112","article-title":"A Case of musk antibody-positive myasthenia gravis patient mimicking amyotrophic lateral sclerosis with four videofluoroscopic examinations","volume":"19","author":"Kasahara","year":"2021","journal-title":"Oral Sci Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.amjmed.2011.11.030","article-title":"Lead poisoning mimicking amyotrophic lateral sclerosis: an adverse effect of rituals","volume":"125","author":"Bachmeyer","year":"2012","journal-title":"Am J Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.neurol.2019.12.004","article-title":"Neuromuscular manifestations of lead poisoning in opium and herbal users in Iran","volume":"176","author":"Okhovat","year":"2020","journal-title":"Rev Neurol (Paris)."},{"key":"B77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/mus.10371","article-title":"Hexosaminidase a deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis","volume":"28","author":"Drory","year":"2003","journal-title":"Muscle Nerve."},{"key":"B78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/S0004-282X2009000100024","article-title":"Late-onset hexosaminidase a deficiency mimicking primary lateral sclerosis","volume":"67","author":"Godeiro-Junior","year":"2009","journal-title":"Arq Neuropsiquiatr."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","article-title":"Lifetime risk and heritability of amyotrophic lateral sclerosis","volume":"76","author":"Ryan","year":"2019","journal-title":"JAMA Neurol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2014.04.013","article-title":"Dissection of genetic factors associated with amyotrophic lateral sclerosis","author":"Leblond","year":"2014","journal-title":"Exp Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ana.21580","article-title":"Familial aggregation of amyotrophic lateral sclerosis","volume":"66","author":"Fang","year":"2009","journal-title":"Ann Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/14737159.2020.1779060","article-title":"Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: how common are common mutations in ALS genes?","volume":"20","author":"Perrone","year":"2020","journal-title":"Expert Rev Mol Diagn."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1007\/s00415-021-10521-w","article-title":"Targeted sequencing panels in italian ALS patients support different etiologies in the ALS\/Ftd continuum","volume":"268","author":"Bartoletti-Stella","year":"2021","journal-title":"J Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.neurobiolaging.2012.09.006","article-title":"Genetic analysis and sod1 mutation screening in iranian amyotrophic lateral sclerosis patients","volume":"34","author":"Alavi","year":"2013","journal-title":"Neurobiol Aging"},{"key":"B85","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neurobiolaging.2013.07.016","article-title":"Repeat expansion in c9orf72 is not a major cause of amyotrophic lateral sclerosis among iranian patients","volume":"35","author":"Alavi","year":"2014","journal-title":"Neurobiol Aging."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e802","DOI":"10.1212\/WNL.0000000000008869","article-title":"ALS phenotype is influenced by age, sex, and genetics: a population-based study","volume":"94","author":"Chio","year":"2020","journal-title":"Neurology."},{"key":"B87","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neurol.2020.06.010","article-title":"Fus mutation is probably the most common pathogenic gene for Jals, Especially Sporadic Jals","volume":"177","author":"Chen","year":"2021","journal-title":"Rev Neurol (Paris)."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","article-title":"Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology","volume":"53","author":"van Rheenen","year":"2021","journal-title":"Nat Genet."},{"key":"B89","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/mus.24198","article-title":"Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research","volume":"49","author":"Su","year":"2014","journal-title":"Muscle Nerve."},{"key":"B90","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1-2 trial of antisense oligonucleotide tofersen for sod1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N Engl J Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00415-018-8968-7","article-title":"Kennedy's Disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease","volume":"266","author":"Breza","year":"2019","journal-title":"J Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"CD001447","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"2012","author":"Miller","year":"2012","journal-title":"The Cochrane Datab Syst Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s004150200071","article-title":"A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis","volume":"249","author":"Bensimon","year":"2002","journal-title":"J Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/146608202317576507","article-title":"Long-term safety of riluzole in amyotrophic lateral sclerosis","volume":"3","author":"Lacomblez","year":"2002","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"B95","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/21678421.2017.1361442","article-title":"Post-Hoc Analysis of Mci186-17, the extension study to mci186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis","volume":"18","author":"Takahashi","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B96","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3109\/21678421.2014.959024","article-title":"Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (Mci-186) in Amyotrophic lateral sclerosis patients","volume":"15","author":"Abe","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B97","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Writing","year":"2017","journal-title":"Lancet Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10072-018-3653-2","article-title":"Huiwang, Zeng Y, Qinwang, et al. Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis-a systematic review and meta-analysis","volume":"40","author":"Luo","year":"2019","journal-title":"Neurol Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"101590","DOI":"10.1016\/j.eclinm.2022.101590","article-title":"Intravenous edaravone treatment in ALS and survival: an exploratory, retrospective, administrative claims analysis","volume":"52","author":"Brooks","year":"2022","journal-title":"EClinicalMedicine."},{"key":"B101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/21678421.2017.1362440","article-title":"A safety analysis of edaravone (Mci-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies","volume":"18","author":"Kalin","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B102","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N Engl J Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/jnnp-2022-329024","article-title":"Effect of sodium phenylbutyrate\/taurursodiol on tracheostomy\/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the centaur trial","volume":"93","author":"Paganoni","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mus.27091","article-title":"Long-term survival of participants in the centaur trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis","volume":"63","author":"Paganoni","year":"2021","journal-title":"Muscle Nerve."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for Sod1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med."},{"key":"B107","volume-title":"Evaluating the Efficacy and Safety of Tofersen in Adults with ALS and a Sod1 Mutation: Results from the Phase 3 Valor Trial and Open-Label Extension","author":"Miller","year":"2022"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.1628","article-title":"Concise review: stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future","volume":"32","author":"Lunn","year":"2014","journal-title":"Stem Cells."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1371\/journal.pmed.0040039","article-title":"Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord","volume":"4","author":"Yan","year":"2007","journal-title":"PLoS Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of Gdnf with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol Ther."},{"key":"B111","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cne.22022","article-title":"Human neural stem cell grafts in the spinal cord of sod1 transgenic rats: differentiation and structural integration into the segmental motor circuitry","volume":"514","author":"Xu","year":"2009","journal-title":"J Comp Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e11852","DOI":"10.1371\/journal.pone.0011852","article-title":"Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord","volume":"5","author":"Rossi","year":"2010","journal-title":"PLoS ONE."},{"key":"B113","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neulet.2011.03.017","article-title":"Dual Transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in sod1 transgenic rats","volume":"494","author":"Xu","year":"2011","journal-title":"Neurosci Lett."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/mt.2013.108","article-title":"Synergistic effects of gdnf and vegf on lifespan and disease progression in a familial ALS Rat Model","volume":"21","author":"Krakora","year":"2013","journal-title":"Mol Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuroscience.2013.05.034","article-title":"Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model","volume":"248","author":"Marconi","year":"2013","journal-title":"Neuroscience."},{"key":"B116","doi-asserted-by":"publisher","first-page":"783122","DOI":"10.3389\/fneur.2021.783122","article-title":"The safety and efficacy of stem cell therapy as an emerging therapy for ALS: a systematic review of controlled clinical trials","volume":"12","author":"Aljabri","year":"2021","journal-title":"Front Neurol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41536-021-00131-5","article-title":"Looking backward to move forward: a meta-analysis of stem cell therapy in amyotrophic lateral sclerosis","volume":"6","author":"Morata-Tarifa","year":"2021","journal-title":"NPJ Regen Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jns.2016.01.051","article-title":"Intraspinal delivery of bone marrow stromal cell-derived neural stem cells in patients with amyotrophic lateral sclerosis: a safety and feasibility study","volume":"362","author":"Nafissi","year":"2016","journal-title":"J Neurol Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/mus.27472","article-title":"A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis","volume":"65","author":"Cudkowicz","year":"2022","journal-title":"Muscle Nerve."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1212\/WNL.0b013e3181bc01a4","article-title":"Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive\/behavioral impairment (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"CD007425","DOI":"10.1002\/14651858.CD007425.pub2","article-title":"Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease","volume":"4","author":"Ng","year":"2009","journal-title":"The Cochrane Datab. Syst Rev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e0179796","DOI":"10.1371\/journal.pone.0179796","article-title":"The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: a population- based study of consultations, interventions and costs","volume":"12","author":"Galvin","year":"2017","journal-title":"PLoS ONE."},{"key":"B123","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12913-015-1229-x","article-title":"Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study","volume":"15","author":"Galvin","year":"2015","journal-title":"BMC Health Serv Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.nrleng.2011.01.010","article-title":"Rivera FJ, Oreja Guevara C, Sanz Gallego I, San Jose Valiente B, Santiago Recuerda A, Gomez Mendieta MA, et al. Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit","volume":"26","author":"Rodriguez","year":"2011","journal-title":"Neurologia."},{"key":"B125","doi-asserted-by":"publisher","first-page":"105710","DOI":"10.1016\/j.bandc.2021.105710","article-title":"Behavioural changes predict poorer survival in amyotrophic lateral sclerosis","volume":"150","author":"Nguyen","year":"2021","journal-title":"Brain Cogn."},{"key":"B126","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nut.2017.11.010","article-title":"Influence of a multidisciplinary protocol on nutritional status at diagnosis in amyotrophic lateral sclerosis","volume":"48","author":"Lopez-Gomez","year":"2018","journal-title":"Nutrition."},{"key":"B127","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/mus.27194","article-title":"Assessment of feasibility and utility of universal referral to specialty palliative care in a multidisciplinary amyotrophic lateral sclerosis clinic: a cohort study","volume":"63","author":"Hafer","year":"2021","journal-title":"Muscle Nerve."},{"key":"B128","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/mus.26838","article-title":"The use of telehealth to enhance care in ALS and other neuromuscular disorders","volume":"61","author":"Haulman","year":"2020","journal-title":"Muscle Nerve."},{"key":"B129","first-page":"173","article-title":"Rehabilitation techniques for patients with amyotrophic lateral sclerosis","volume":"53","author":"Sinaki","year":"1978","journal-title":"Mayo Clin Proc."},{"key":"B130","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/NPT.0b013e31819912d0","article-title":"A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis","volume":"33","author":"Lui","year":"2009","journal-title":"J Neurol Phys Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/PHM.0000000000001419","article-title":"Effects of exercise in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"99","author":"Meng","year":"2020","journal-title":"Am J Phys Med Rehabil."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/ijerph18031074","article-title":"Systematic review of therapeutic physical exercise in patients with amyotrophic lateral sclerosis over time","volume":"18","author":"Ortega-Hombrados","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B133","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mus.24202","article-title":"Rehabilitation in amyotrophic lateral sclerosis: why it matters","volume":"50","author":"Majmudar","year":"2014","journal-title":"Muscle Nerve."},{"key":"B134","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1017\/S1478951521000584","article-title":"Effects of prolonged interruption of rehabilitation routines in amyotrophic lateral sclerosis patients","volume":"20","author":"Goncalves","year":"2022","journal-title":"Palliat Support Care."},{"key":"B135","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/CND.0b013e31821c5623","article-title":"Shoulder pain in amyotrophic lateral sclerosis","volume":"13","author":"Ho","year":"2011","journal-title":"J Clin Neuromuscul Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","article-title":"Efns guidelines on the clinical management of amyotrophic lateral sclerosis (Mals)\u2013revised report of an Efns task force","volume":"19","year":"2012","journal-title":"Eur J Neurol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/21678421.2012.751614","article-title":"Prevalence and characteristics of pain in early and late stages of ALS","volume":"14","author":"Rivera","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B138","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/DNND.S146949","article-title":"Physical therapy for individuals with amyotrophic lateral sclerosis: current insights","volume":"8","author":"Bello-Haas","year":"2018","journal-title":"Degener Neurol Neuromuscul Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/17482960903270359","article-title":"Session 1 joint opening session","volume":"10","author":"Miller","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mus.25712","article-title":"Improving symptom management for people with amyotrophic lateral sclerosis","volume":"57","author":"Nicholson","year":"2018","journal-title":"Muscle Nerve."},{"key":"B141","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/1460-6984.12357","article-title":"Speech Deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms","volume":"53","author":"Makkonen","year":"2018","journal-title":"Int J Lang Commun Disord."},{"key":"B142","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/17482960802379004","article-title":"Dysarthria in amyotrophic lateral sclerosis: a review","volume":"11","author":"Tomik","year":"2010","journal-title":"Amyotroph Lateral Scler."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1044\/2015_JSLHR-S-14-0270","article-title":"Is There a Role for Exercise in the Management of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis?","volume":"58","author":"Plowman","year":"2015","journal-title":"J Speech Lang Hear Res."},{"key":"B144","volume-title":"The Impact of Lingual Resistance Training in Two Individuals with Amyotrophic Lateral Sclerosis: A Case Series","author":"Robison","year":"2015"},{"key":"B145","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/NRE-141200","article-title":"Dysarthria and dysphagia in amyotrophic lateral sclerosis with spinal onset: a study of quality of life related to swallowing","volume":"36","author":"da Costa Franceschini","year":"2015","journal-title":"NeuroRehabilitation."},{"key":"B146","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jcomdis.2016.04.002","article-title":"Oral motor functions, speech and communication before a definitive diagnosis of amyotrophic lateral sclerosis","volume":"61","author":"Makkonen","year":"2016","journal-title":"J Commun Disord."},{"key":"B147","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00455-021-10261-z","article-title":"A novel method for triggering the swallowing reflex in patients with amyotrophic lateral sclerosis: the ishizaki press method","volume":"37","author":"Ishizaki","year":"2022","journal-title":"Dysphagia."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1016\/j.jpainsymman.2021.12.005","article-title":"Prevalence of sialorrhea among amyotrophic lateral sclerosis patients: a systematic review and meta-analysis","volume":"63","author":"Wang","year":"2022","journal-title":"J Pain Symptom Manage."},{"key":"B149","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/jnnp-2016-313614","article-title":"Sialorrhoea and reversals in ALS functional rating scale","volume":"88","author":"Pinto","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4187\/respcare.07005","article-title":"The oral secretion scale and prognostic factors for survival in subjects with amyotrophic lateral sclerosis","volume":"65","author":"Cazzolli","year":"2020","journal-title":"Respir Care."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2016.1221433","article-title":"A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis","volume":"18","author":"McGeachan","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B152","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4187\/respcare.02856","article-title":"Review of options for treating sialorrhea in amyotrophic lateral sclerosis","volume":"60","author":"Banfi","year":"2015","journal-title":"Respir Care."},{"key":"B153","doi-asserted-by":"publisher","first-page":"E1453","DOI":"10.1503\/cmaj.191721","article-title":"Canadian best practice recommendations for the management of amyotrophic lateral sclerosis","volume":"192","author":"Shoesmith","year":"2020","journal-title":"CMAJ."},{"key":"B154","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jpainsymman.2008.02.006","article-title":"Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis","volume":"37","author":"Stone","year":"2009","journal-title":"J Pain Symptom Manage."},{"key":"B155","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin a versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord."},{"key":"B156","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/lary.25444","article-title":"The role of radiation therapy in the management of sialorrhea: a systematic review","volume":"126","author":"Hawkey","year":"2016","journal-title":"Laryngoscope."},{"key":"B157","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/CND.0000000000000273","article-title":"The role of radiation therapy and botulinum toxin injections in the management of sialorrhea in patients with amyotrophic lateral sclerosis: a systematic review","volume":"21","author":"Shehee","year":"2020","journal-title":"J Clin Neuromuscul Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph Lateral Scler."},{"key":"B159","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.clnu.2011.06.004","article-title":"Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients","volume":"30","author":"Genton","year":"2011","journal-title":"Clin Nutr."},{"key":"B160","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clnu.2017.09.003","article-title":"Espen guideline clinical nutrition in neurology","volume":"37","author":"Burgos","year":"2018","journal-title":"Clin Nutr."},{"key":"B161","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1073\/pnas.4.12.370","article-title":"A biometric study of human basal metabolism","volume":"4","author":"Harris","year":"1918","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.otc.2013.08.005","article-title":"Dysphagia in stroke, neurodegenerative disease, and advanced dementia","volume":"46","author":"Altman","year":"2013","journal-title":"Otolaryngol Clin North Am."},{"key":"B163","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/21678421.2017.1360355","article-title":"Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review","volume":"19","author":"Kellogg","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B164","volume-title":"National Institute for Health and Care Excellence: Clinical Guidelines. Motor Neurone Disease: Assessment and Management. National Institute for Health and Care Excellence: Clinical Guidelines","year":"2016"},{"key":"B165","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/mus.26408","article-title":"Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis","volume":"59","author":"Pattee","year":"2019","journal-title":"Muscle Nerve."},{"key":"B166","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/21678421.2017.1313868","article-title":"The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States","volume":"18","author":"Plowman","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B167","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/CND.0000000000000281","article-title":"Evaluation and management of dysphagia in amyotrophic lateral sclerosis: a survey of speech-language pathologists' clinical practice","volume":"21","author":"Epps","year":"2020","journal-title":"J Clin Neuromuscul Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/nmo.12700","article-title":"Discriminant ability of the eating assessment tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis","volume":"28","author":"Plowman","year":"2016","journal-title":"Neurogastroenterol Motil."},{"key":"B169","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(15)00104-0","article-title":"Gastrostomy in patients with amyotrophic lateral sclerosis (progas): a prospective cohort study","volume":"14","year":"2015","journal-title":"Lancet Neurol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/21678421.2019.1643374","article-title":"Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement","volume":"20","author":"Barone","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B171","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/brainsci9090223","article-title":"A comprehensive examination of percutaneous endoscopic gastrostomy and its association with amyotrophic lateral sclerosis patient outcomes","volume":"9","author":"Bond","year":"2019","journal-title":"Brain Sci."},{"key":"B172","doi-asserted-by":"publisher","first-page":"CD008096","DOI":"10.1002\/14651858.CD008096.pub4","article-title":"percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances","volume":"5","author":"Gomes","year":"2015","journal-title":"Cochrane Datab. Syst. Rev."},{"key":"B173","doi-asserted-by":"publisher","first-page":"pub4","DOI":"10.1002\/14651858.CD004427.pub4","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","volume":"10","author":"Radunovic","year":"2017","journal-title":"Cochrane Datab Syst Rev."},{"key":"B174","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/apmr.2001.18053","article-title":"Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders","volume":"82","author":"Fromageot","year":"2001","journal-title":"Arch Phys Med Rehabil."},{"key":"B175","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/21678421.2017.1353097","article-title":"Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients","volume":"18","author":"Enache","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B176","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12931-017-0624-8","article-title":"The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis","volume":"18","author":"Tilanus","year":"2017","journal-title":"Respir Res."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00415-020-09751-1","article-title":"Prognostic role of slow vital capacity in amyotrophic lateral sclerosis","volume":"267","author":"Calvo","year":"2020","journal-title":"J Neurol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"e17893","DOI":"10.1371\/journal.pone.0017893","article-title":"Capnography for assessing nocturnal hypoventilation and predicting compliance with subsequent noninvasive ventilation in patients with ALS","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS ONE."},{"key":"B179","doi-asserted-by":"publisher","first-page":"e75324","DOI":"10.1371\/journal.pone.0075324","article-title":"Nocturnal hypoxia in ALS is related to cognitive dysfunction and can occur as clusters of desaturations","volume":"8","author":"Park","year":"2013","journal-title":"PLoS ONE."},{"key":"B180","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/17482960701262392","article-title":"Early use of non-invasive ventilation prolongs survival in subjects with ALS","volume":"8","author":"Lechtzin","year":"2007","journal-title":"Amyotroph Lateral Scler."},{"key":"B181","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fneur.2018.00578","article-title":"Associative Increases in amyotrophic lateral sclerosis survival duration with non-invasive ventilation initiation and usage protocols","volume":"9","author":"Khamankar","year":"2018","journal-title":"Front Neurol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/ene.13547","article-title":"Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis","volume":"25","author":"Vitacca","year":"2018","journal-title":"Eur J Neurol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mus.23282","article-title":"Respiratory therapies for amyotrophic lateral sclerosis: a primer","volume":"46","author":"Gruis","year":"2012","journal-title":"Muscle Nerve."},{"key":"B184","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/17482968.2010.535541","article-title":"A Comparison of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis","volume":"12","author":"Senent","year":"2011","journal-title":"Amyotroph Lateral Scler."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1378\/chest.125.4.1400","article-title":"Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis","volume":"125","author":"Sancho","year":"2004","journal-title":"Chest."},{"key":"B186","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.27417","article-title":"Lung volume recruitment improves volitional airway clearance in amyotrophic lateral sclerosis","volume":"64","author":"Cleary","year":"2021","journal-title":"Muscle Nerve."},{"key":"B187","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00415-021-10651-1","article-title":"A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis","volume":"269","author":"Beswick","year":"2022","journal-title":"J Neurol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1474-4422(16)30358-1","article-title":"Pain in amyotrophic lateral sclerosis","volume":"16","author":"Chio","year":"2017","journal-title":"Lancet Neurol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"CD005226","DOI":"10.1002\/14651858.CD005226.pub3","article-title":"Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease","volume":"2013","author":"Brettschneider","year":"2013","journal-title":"The Cochrane Datab. Syst Rev."},{"key":"B190","doi-asserted-by":"publisher","first-page":"CD011776","DOI":"10.1002\/14651858.CD011776.pub2","article-title":"Symptomatic treatments for amyotrophic lateral sclerosis\/motor neuron disease","volume":"1","author":"Ng","year":"2017","journal-title":"The Cochrane Datab. Syst Rev."},{"key":"B191","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjmed.2018.07.012","article-title":"Motor neuron disease: pathophysiology, diagnosis, and management","volume":"132","author":"Foster","year":"2019","journal-title":"Am J Med."},{"key":"B192","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"Efns guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mus.20341","article-title":"Muscle cramps","volume":"32","author":"Miller","year":"2005","journal-title":"Muscle Nerve."},{"key":"B195","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1016\/j.toxicon.2020.11.478","article-title":"Results of botulinum toxin therapy for spasticity in patients with amyotrophic lateral sclerosis","volume":"190","author":"Rufin","year":"2021","journal-title":"Toxicon."},{"key":"B196","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1474-4422(18)30406-X","article-title":"Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (canals): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Riva","year":"2019","journal-title":"Lancet Neurol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/17482960802430773","article-title":"Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease","volume":"10","author":"Bedlack","year":"2009","journal-title":"Amyotroph Lateral Scler."},{"key":"B198","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2217\/nmt-2020-0026","article-title":"Efficacy and safety of mexiletine in amyotrophic lateral sclerosis: a systematic review of randomized controlled trials","volume":"10","author":"Adiao","year":"2020","journal-title":"Neurodegener Dis Manag."},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005044.pub3","article-title":"Quinine for muscle cramps","author":"El-Tawil","year":"2015","journal-title":"The Cochrane Datab. Syst Rev."},{"key":"B200","doi-asserted-by":"publisher","first-page":"CD009402","DOI":"10.1002\/14651858.CD009402.pub3","article-title":"Magnesium for skeletal muscle cramps","volume":"9","author":"Garrison","year":"2020","journal-title":"The Cochrane Datab. Syst Rev."},{"key":"B201","doi-asserted-by":"publisher","first-page":"CD011005","DOI":"10.1002\/14651858.CD011005.pub2","article-title":"Treatment of fatigue in amyotrophic lateral sclerosis\/motor neuron disease","volume":"1","author":"Gibbons","year":"2018","journal-title":"The Cochrane Datab. Syst Rev."},{"key":"B202","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/17482960802028890","article-title":"Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and Alsfrs","volume":"9","author":"Rosenfeld","year":"2008","journal-title":"Amyotroph Lateral Scler."},{"key":"B203","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00415-015-7981-3","article-title":"Pseudobulbar affect (Pba) in an incident ALS cohort: results from the apulia registry (slap)","volume":"263","author":"Tortelli","year":"2016","journal-title":"J Neurol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1586\/ern.11.68","article-title":"Pseudobulbar Affect: The Spectrum of Clinical Presentations, Etiologies and Treatments","volume":"11","author":"Miller","year":"2011","journal-title":"Expert Rev Neurother."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","article-title":"Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial","volume":"63","author":"Brooks","year":"2004","journal-title":"Neurology."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2147\/NDT.S30713","article-title":"Evaluating the safety and efficacy of dextromethorphan\/quinidine in the treatment of pseudobulbar affect","volume":"10","author":"Schoedel","year":"2014","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B207","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/14660820310017344","article-title":"A survey of clinicians' practice in the symptomatic treatment of ALS","volume":"4","author":"Forshew","year":"2003","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"B208","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/17843286.2016.1173941","article-title":"Noninvasive ventilation in amyotrophic lateral sclerosis: effects on sleep quality and quality of life","volume":"71","author":"Vandoorne","year":"2016","journal-title":"Acta Clin Belg."},{"key":"B209","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","article-title":"Prevalence and patterns of cognitive impairment in sporadic ALS","volume":"65","author":"Ringholz","year":"2005","journal-title":"Neurology."},{"key":"B210","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jnnp-2013-307223","article-title":"Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy","volume":"86","author":"Montuschi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B211","doi-asserted-by":"publisher","first-page":"e0137921","DOI":"10.1371\/journal.pone.0137921","article-title":"Cognitive impairment in chinese patients with sporadic amyotrophic lateral sclerosis","volume":"10","author":"Cui","year":"2015","journal-title":"PLoS ONE."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1007\/s00415-017-8619-4","article-title":"Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter italian cohort","volume":"264","author":"Trojsi","year":"2017","journal-title":"J Neurol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s10072-020-04624-x","article-title":"Which are the factors influencing niv adaptation and tolerance in ALS patients?","volume":"42","author":"Russo","year":"2021","journal-title":"Neurol Sci."},{"key":"B214","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0269216317709965","article-title":"Caregiver burden in amyotrophic lateral sclerosis: a systematic review","volume":"32","author":"de Wit","year":"2018","journal-title":"Palliat Med."},{"key":"B215","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ene.14130","article-title":"Respiratory function and cognitive profile in amyotrophic lateral sclerosis","volume":"27","author":"Huynh","year":"2020","journal-title":"Eur J Neurol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(12)70014-5","article-title":"Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a c9orf72 repeat expansion: a population-based cohort study","volume":"11","author":"Byrne","year":"2012","journal-title":"Lancet Neurol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1474-4422(12)70320-4","article-title":"Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Boxer","year":"2013","journal-title":"Lancet Neurol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.JGP.0000231744.69631.33","article-title":"Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia","volume":"15","author":"Mendez","year":"2007","journal-title":"Am J Geriatr Psychiatry."},{"key":"B219","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/jnnp.71.4.482","article-title":"The effect of non-invasive positive pressure ventilation (nippv) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study","volume":"71","author":"Newsom-Davis","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B220","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s10072-022-05931-1","article-title":"Overcoming therapeutic nihilism. Breaking bad news of amyotrophic lateral sclerosis-a patient-centred perspective in rare diseases","volume":"43","author":"Maksymowicz","year":"2022","journal-title":"Neurol Sci"},{"key":"B221","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12883-020-02004-8","article-title":"Kruitwagen-van Reenen ET, Westeneng HJ, Visser-Meily JMA, et al. Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide","volume":"20","author":"van Eenennaam","year":"2020","journal-title":"BMC Neurol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09638288.2021.2002436","article-title":"Healthcare professionals' involvement in breaking bad news to newly diagnosed patients with motor neurodegenerative conditions: a qualitative study","volume":"8","author":"Anestis","year":"2021","journal-title":"Disabil Rehabil"},{"key":"B223","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1007\/s00415-020-10203-z","article-title":"A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis","volume":"268","author":"Beswick","year":"2021","journal-title":"J Neurol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1176\/appi.neuropsych.21040092","article-title":"Embedded psychiatric services in a multidisciplinary amyotrophic lateral sclerosis clinic: an assessment of patient needs and perceptions","volume":"34","author":"Hardy","year":"2022","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B225","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/21678421.2015.1038276","article-title":"Cognitive behavioural therapy and quality of life in psychologically distressed patients with amyotrophic lateral sclerosis and their caregivers: results of a prematurely stopped randomized controlled trial","volume":"16","author":"van Groenestijn","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B226","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/ene.13246","article-title":"Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial","volume":"24","author":"Pagnini","year":"2017","journal-title":"Eur J Neurol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12904-016-0097-4","article-title":"Family caregivers' accounts of caring for a family member with motor neurone disease in norway: a qualitative study","volume":"15","author":"Lerum","year":"2016","journal-title":"BMC Palliat Care."},{"key":"B228","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1212\/01.wnl.0000233840.41688.df","article-title":"Caregiver time use in ALS","volume":"67","author":"Chio","year":"2006","journal-title":"Neurology."},{"key":"B229","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0885-3924(03)00323-3","article-title":"Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers","volume":"26","author":"Kaub-Wittemer","year":"2003","journal-title":"J Pain Symptom Manage."},{"key":"B230","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1212\/01.wnl.0000257093.53430.a8","article-title":"A longitudinal study on quality of life and depression in ALS patient-caregiver couples","volume":"68","author":"Gauthier","year":"2007","journal-title":"Neurology."},{"key":"B231","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-510X(96)00099-8","article-title":"Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation","volume":"139","author":"Cazzolli","year":"1996","journal-title":"J Neurol Sci."},{"key":"B232","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/21678421.2017.1317812","article-title":"Decision-making for tracheostomy in amyotrophic lateral sclerosis (ALS): a retrospective study","volume":"18","author":"Ceriana","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B233","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/practneurol-2018-002109","article-title":"Tracheostomy in motor neurone disease","volume":"19","author":"Turner","year":"2019","journal-title":"Pract Neurol."},{"key":"B234","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/14660820500515021","article-title":"Predictors and course of elective long-term mechanical ventilation: a prospective study of ALS patients","volume":"7","author":"Rabkin","year":"2006","journal-title":"Amyotroph Lateral Scler."},{"key":"B235","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2014.06.050","article-title":"Tracheostomy ventilation in ALS: a Japanese Bias","volume":"344","author":"Vianello","year":"2014","journal-title":"J Neurol Sci."},{"key":"B236","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","article-title":"respiratory failure in amyotrophic lateral sclerosis","volume":"155","author":"Niedermeyer","year":"2019","journal-title":"Chest."},{"key":"B237","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.clineuro.2017.07.004","article-title":"Physician perceptions about living organ donation in patients with amyotrophic lateral sclerosis","volume":"160","author":"Ansari","year":"2017","journal-title":"Clin Neurol Neurosurg."},{"key":"B238","first-page":"24","article-title":"Patient's rights charter in Iran","volume":"52","author":"Parsapoor","year":"2014","journal-title":"Acta Med Iran"},{"key":"B239","first-page":"13","article-title":"Ethical and Practical Considerations on Refusal of Medical Treatment","volume":"7","author":"Madani","year":"2014","journal-title":"Iran J Med Ethics History Med."},{"key":"B240","first-page":"2","article-title":"End-of-life care ethical decision-making: shiite scholars' views","volume":"7","author":"Mobasher","year":"2014","journal-title":"J Med Ethics Hist Med."},{"key":"B241","first-page":"1","article-title":"Euthanasia: an analytical review based on the article 372 of the islamic penal code","volume":"9","author":"Hejazi","year":"2017","journal-title":"Iran J Med Ethics History Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1154579\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T11:13:09Z","timestamp":1702552389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1154579\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":241,"alternative-id":["10.3389\/fneur.2023.1154579"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1154579","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"article-number":"1154579"}}